Barbara Eichhorst, MD from University of Cologne, Cologne, Germany discusses the economic burden of treating chronic lymphocytic leukemia (CLL). A solution Dr Eichhorst proposes is raising the price of treatment in the beginning, but ensuring that this treatment eradicates the disease. Consequently the patient does not have to pay for continuous treatment. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.
Lessening the economic burden of treating CLL
